Research desk · LLY · NYSE
LLY Stock
SEC financials, peer compare, and chart. Scores open the matching desk. Research only — not advice.
ELI LILLY AND COMPANY · Pharmaceutical Preparations
ELI LILLY AND COMPANY financial statements, chart, and peer compare from SEC filings.
ELI LILLY AND COMPANY (LLY) discovers, develops, or markets pharmaceutical products.
- Market cap
- $1.16T
- P/E
- 48.02
- Op. margin
- 66.74%
- Profit margin
- 32.15%
- FCF margin
- 8.94%
- ROE
- 96.60%
Related Health Care stocks: MRK stock financials · BMY stock financials · AMGN stock financials · GILD stock financials · REGN stock financials
LLY financial statements
Each Compare name is its own block of years. Filing lines are SEC reports; P/E and price sit on that name’s TTM column only.
LLY stock peer compare
Each bar is that name’s percent vs its last TTM, on one zero line. Zero is unchanged. This ticker is the black bar.
Focus chart
Zero is unchanged vs last TTM. Every name is a percent for the metric you pick.
LLY stock peer headlines
Yahoo Finance RSS for LLY and the names in Compare.
| Ticker | Date | Headline |
|---|---|---|
| Loading headlines… | ||
LLY stock price chart
Overlays follow the Compare table.
LLY stock — research snapshot
Screen strengths and watchouts for LLY stock from the latest Misprise snapshot.
Strengths
- ROA 16.2% — strong returns on assets.
- ROE 96.6% — efficient equity returns.
- Operating margin 66.7% — solid operating leverage.
- Profit margin 32.2% — durable bottom-line quality.
- Revenue CAGR 5Y 21.6% — durable top-line compound.
Watchouts
- Debt/equity 2.30 — elevated leverage risk.
- Rev CAGR 5Y 21.6%
- Rev CAGR 3Y 31.7%
- EPS CAGR 5Y 27.6%
- EPS CAGR 3Y 49.3%
- FCF CAGR 5Y 11.9%
- FCF CAGR 3Y 16.1%
LLY stock FAQs
Short answers for LLY stock — statements, sector, and how this page is meant to be used.
What is LLY stock?
ELI LILLY AND COMPANY (LLY) discovers, develops, or markets pharmaceutical products. LLY stock sits in Health Care (Pharmaceutical Preparations), listed on NYSE.
Where can I find ELI LILLY AND COMPANY financial statements?
ELI LILLY AND COMPANY financial statements — income statement, balance sheet, and cash flow — are on this LLY stock page, parsed from SEC 10-K and 10-Q filings. Use Annual or Quarterly, then the statement tabs. Research only.
What happened to LLY stock?
This page is a research snapshot of ELI LILLY AND COMPANY (LLY) from the latest SEC filings in the Misprise database as of TTM. It is not a news feed or a delisting notice. Open the financial statements, chart, and peer compare below, then read the filings. Research only — not financial advice.
Does this page show the LLY stock price?
The live chart on this LLY stock page is the same TradingView chart as the screener. Statement tables use SEC filings. Any price or multiple on the TTM column is a market snapshot from the last seed, not a real-time quote. Research only.
What sector is LLY stock in?
ELI LILLY AND COMPANY is classified in Pharmaceutical Preparations, inside the Health Care sector, and trades on NYSE. This page is a research snapshot, not a full company profile.
How do I read LLY financial statements?
Start with this ticker’s block (TTM, then its fiscal years or quarters). Each Compare name is a separate block of its own periods — not mixed by year. A blank is a period we do not have, not a zero. Research only — not a buy or sell.
Where does the LLY statement data come from?
Income, balance sheet, and cash-flow lines are parsed from SEC company filings (10-K / 10-Q and 20-F). TTM is the last four reported quarters added together, not a separate filing. P/E, forward P/E, price, and market cap are a market quote at last seed — trailing P/E from the quote when available, otherwise last price divided by TTM EPS. They are not 10-K line items and appear on the TTM column only. Research only — not financial advice.
Where can I find the LLY income statement, balance sheet, and cash flow?
On this LLY stock page, open Financial statements and use the Income, Balance sheet, and Cash flow tabs. Growth and valuation sit under More. Filing figures are from SEC reports; valuation multiples are the market snapshot described above.
What is the Misprise Score for LLY stock?
LLY stock currently scores 95/100 (Exceptional (85–100)). ELI LILLY AND COMPANY clears the high end of the Misprise screen — multi-year growth, profitability, and balance-sheet quality line up together. The score is a screen of quality, growth, and balance-sheet inputs — not a price target. Compare it in the Misprise screener; it is not a separate score page.
How is the LLY comparison winner decided?
Lead and Tie follow the number printed on each factor row, not a blended category score. Growth, quality, score, current ratio, and coverage: the higher figure leads. Value multiples (P/E, PEG, P/B, P/S) and debt ratios: the lower figure leads. Tie appears only when those printed numbers match. The header winner is whoever takes more of those five rows. CAGR uses the 5-year horizon and drops to 3-year only when both names report it. Research only — not a buy or sell.
What is the Anomaly Score on this LLY page?
Anomaly Score is how unusual a filing pattern is versus this company’s own history and its industry — not the same as Misprise Score. A high anomaly with a weak Misprise Score is often a noisy name. Open the anomaly detector to see the flag. Research only — not financial advice.
What does the green grant dot mean on LLY stock?
A green circle next to the title means this ticker appears in the Misprise grants calendar with a recent federal award (USASpending / SAM). Tap the dot for date, agency, and amount when available. It is a research flag only — not a buy or sell signal.
Is LLY stock a buy?
No recommendation either way. This LLY stock page organizes statements, ratios, and peers so you can do your own work. It is educational only — not advice to buy or sell ELI LILLY AND COMPANY.